16 Results for "

HIPK2

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "HIPK2" in MCE Product Catalog:

  • Isoforms Recommended:
  • Recombinant Proteins Recommended:
6
6 Publications Verification
Cat. No.: HY-100464
CAS No.: 1639895-85-4
Purity:  99.03%
Target:  

DYRK

Research Areas:  

Cancer

tBID is a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2) with an IC50 of 0.33 μM.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-U00439A
CAS No.: 2321337-71-5
Target:  

DYRK

Research Areas:  

Cancer

Protein kinase inhibitor 1 hydrochloride is a potent HIPK2 inhibitor, with IC50s of 136 and 74 nM for HIPK1 and HIPK2, and a Kd of 9.5 nM for HIPK2.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-135906
CAS No.: 1085822-09-8
Purity:  ≥99.0%
Research Areas:  

Cancer

CK2/ERK8-IN-1 is a dual casein kinase 2 (CK2) (Ki of 0.25 µM) and ERK8 (MAPK15, ERK7) inhibitor with IC50s of 0.50 μM. CK2/ERK8-IN-1 also binds to PIM1, HIPK2 (homeodomain-interacting protein kinase 2), and DYRK1A with Kis of 8.65 µM, 15.25 µM, and 11.9 µM, respectively. CK2/ERK8-IN-1 has pro-apoptotic efficacy .
loading...
    loading...
Cat. No.: HY-128439
CAS No.: 2232180-74-2
Purity:  98.71%
Target:  

DYRK

Research Areas:  

Cancer

BT173 is a potent homeodomain interacting protein kinase 2 (HIPK2) inhibitor. BT173 binds to HIPK2 and does not inhibit HIPK2 kinase activity but rather, interfered allosterically with the ability of HIPK2 to associate with Smad3. BT173 attenuates renal fibrosis through suppression of the TGF-β1/Smad3 pathway. BT173 can be studied in research for kidney diseases such as renal fibrosis .
loading...
    loading...
Cat. No.: HY-E70830
Target:  

DYRK

Research Areas:  

Cancer

Homeodomain interacting protein kinase 2 (HIPK2) is an evolutionary conserved serine/threonine kinase that regulates gene expression by phosphorylation of transcription factors and accessory components of the transcription machinery. HIPK2 is activated in response to DNA-damaging agents or morphogenic signals. HIPK2 Recombinant Human Active Protein Kinase is a recombinant HIPK2 protein that can be used to study HIPK2-related functions .
loading...
    loading...
Cat. No.: HY-177416
CAS No.: 2624098-97-9
Target:  

DYRK

Research Areas:  

Cancer

MU1787 is a highly selective homeodomain-interacting protein kinase (HIPK) inhibitor with a furopyridine core, and shows improved selectivity against CLKs, with inactivity against DYRK1B, DYRK2, and MLK2/3 in in vitro cellular assays. MU1787 can be used for the research of malignancies .
loading...
    loading...
Cat. No.: HY-RS23297
Research Areas:  

Others

Hipk2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Hipk2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Components

Hipk2 siRNA-1: 5 nmol (HPLC)

Hipk2 siRNA-2: 5 nmol (HPLC)

Hipk2 siRNA-3: 5 nmol (HPLC)

siRNA Negative Control: 5 nmol (HPLC)

FAM-labeled siRNA Negative Control: 5 nmol (HPLC)

GAPDH siRNA Positive Control: 5 nmol (HPLC)

loading...
    loading...
Cat. No.: HY-RS06182
Research Areas:  

Others

HIPK2 Human Pre-designed siRNA Set A contains three designed siRNAs for HIPK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS16856
Research Areas:  

Others

Hipk2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hipk2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-U00439
CAS No.: 1365986-44-2
Target:  

DYRK

Research Areas:  

Cancer

Protein kinase inhibitor 1 is a novel inhibitor of HIPK2 with an IC50 of 74 nM and Kd of 9.5 nM.
loading...
    loading...
Cat. No.: HY-P706148
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: HIPK2; Homeodomain-interacting protein kinase 2; hHIPK2
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-179378
CAS No.: 2968523-32-0
XRF-1021 is an orally active HIPK2 inhibitor (IC50 = 0.18 μM). XRF-1021 reduces the expression of fibrotic markers in TGF-β1 stimulated NRK-49F and HK-2 cells, including Fibronectin, Collagen I and α-SMA. XRF-1021 blocks TGF-β, NF-κB, p53, Wnt/β-catenin, and Notch signaling. XRF-1021 reduces renal injury and fibrosis in vivo. XRF-1021 can be used for the research of chronic kidney disease .
loading...
    loading...
Cat. No.: HY-P82168
Synonyms: hHIPK2; HIPK2; Nbak1; Stank

Host:  

Rabbit

Application:  

WB, ICC/IF, IP, FC

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-100464R
CAS No.: 1639895-85-4
Research Areas:  

Cancer

tBID (Standard) is the analytical standard of tBID (HY-100464). This product is intended for research and analytical applications. tBID is a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2) with an IC50 of 0.33 μM.
loading...
    loading...
Cat. No.: HY-W152736
CAS No.: 33414-49-2
Target:  

DYRK

Research Areas:  

Neurological Disease

2-Methyl-5-acetylphenol is a hydroxylated methylacetophenone that exists in the aerial parts of Cannabis sativa subsp. sativa. 2-Methyl-5-acetylphenol exhibits strong binding affinity to HIPK2. 2-Methyl-5-acetylphenol cannot reverse MPP + (1-methyl-4-phenyl-pyridinium ion)-induced neuronal cytotoxicity. 2-Methyl-5-acetylphenol can be used for Parkinson's disease research .
loading...
    loading...
Cat. No.: HY-122670
CAS No.: 1627962-21-3
Research Areas:  

Cancer

VS-II-173 is a pan-Pim kinase inhibitor with IC50 values ​​of 0.07 μM and 0.02 μM for Pim1 and Pim3, respectively, and a residual activity of 46% for Pim2 at 1 μM. VS-II-173 also inhibits kinases such as HIPK2, PRK2, RSK1, DYRK1a and AMPKα1, selectively inhibiting acute myeloid leukemia (AML) cells with significantly lower toxicity to non-malignant cells (EC50 > 30 μM). VS-II-173 weakens the phosphorylation of substrates such as Stat5 (Y694), MDM2 (S166), Bad (S112), and 4E-BP1 (T37/46) by inhibiting Pim kinase-mediated signaling pathways, blocking pro-survival signals in AML cells and inducing apoptosis. VS-II-173 synergistically enhances anti-AML activity when combined with Daunorubicin (HY-13062A). VS-II-173 can be used in AML research, especially for AML with FLT3-ITD mutations and NPM1 mutations [2].
loading...
    loading...
  • 1